J2185 HCPCS code: Injection, meropenem, 100 mg
J2185 is the HCPCS Level II code for injection, meropenem, 100 mg. In 2024 Medicare paid an average of $0.29 per service for J2185 across 268,997 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 60 per day on outpatient hospital claims. Medicare volume fell 8% from 2022 to 2024 (290,877 to 268,997 services). In 2024, about 309 clinicians billed Medicare for J2185 for 969 beneficiaries; Florida, Texas, Colorado accounted for 76% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2004-01-01 |
| Last action effective | 2004-01-01 |
Who bills J2185 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 309 |
| Medicare beneficiaries | 969 |
| States with claims | 10 |
| Share of services in top 3 states (Florida, Texas, Colorado) | 76% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2185, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 290,877 | 953 | $0.70 | $0.56 |
| 2023 | 270,298 | 992 | $0.54 | $0.43 |
| 2024 | 268,997 | 969 | $0.37 | $0.29 |
States with the most J2185 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 101,550 | $0.29 |
| Texas | 63,292 | $0.29 |
| Colorado | 27,180 | $0.28 |
| Georgia | 24,327 | $0.29 |
| New Jersey | 13,071 | $0.30 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 60 | Prescribing Information |
| practitioner claims | 60 | Prescribing Information |
What changed for J2185
- 2004-01-01: J2185 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2185?
J2185 is the HCPCS Level II code for injection, meropenem, 100 mg. Short descriptor: "Meropenem".
How much does Medicare pay for J2185?
In 2024, the average Medicare payment was $0.29 per service (average allowed $0.37).
Does Medicare cover J2185?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2185 can be billed per day?
60 on outpatient hospital claims; 60 on practitioner claims (NCCI medically unlikely edits).
Related J21 codes
- J2150 — Injection, mannitol, 25% in 50 ml
- J2151 — Injection, mannitol, 250 mg
- J2170 — Injection, mecasermin, 1 mg
- J2175 — Injection, meperidine hydrochloride, per 100 mg
- J2180 — Injection, meperidine and promethazine hcl, up to 50 mg
- J2182 — Injection, mepolizumab, 1 mg
- J2183 — Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
- J2184 — Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2186 — Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2185
- Watch J2185 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2185
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.